One to Watch: DenovoSkin Shows Promise in Reconstructive Surgery, Burns
CUTISS AG’s denovoSkin performed well in a Phase 2 clinical trial of patients undergoing reconstructive skin surgery for various conditions, according to an interim analysis of the data. The full data analysis with the one year follow up will be available in early 2025. DenovoSkin is a personalized, bio-engineered dermo-epidermal human skin graft, created from […]